reconstitution comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Thymosin alpha-1 is supplied as a lyophilized powder in most research settings. The solid dissolves readily in water and in common aqueous buffers, and it is typically reconstituted shortly before use. Solutions are clear and colourless at ordinary working concentrations. Because the peptide is hygroscopic, weighing and reconstitution are usually performed with minimal exposure to ambient air. Aliquots are prepared to avoid repeated freeze-thaw cycles, and working solutions are kept cold.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20 °C or below | Desiccated, protected from light |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity and identity |
| Common synonyms | Thymalfasin, T alpha 1 | Sequence identical to natural fragment |
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
== In popular culture == 60Co is the material encasing a massive nuclear warhead attached to a missile called the Alpha-Omega Doomsday Bomb in the film Beneath the Planet of the Apes (1970). In an episode of 9-1-1 (TV series), a truck illegally transporting 60Co causes a hazardous emergency for a team of firefighters. In the 1959 film, City of Fear, 60Co is central to the plot in which an escaped convict obtains the material, believing it to be heroin and endangering the city of Los Angeles.
== Indications == It is a highly selective dipeptidyl peptidase-4 inhibitor that is typically used as an add on treatment when the first line treatment of metformin is not achieving the expected glycemic goals; though it has been approved for use as a first line treatment when metformin cannot be used.
Henan Corps Hubei Corps Hunan Corps Inner Mongolia Corps Jiangsu Corps Jiangxi Corps Jilin Corps Liaoning Corps Ningxia Corps Qinghai Corps Two mobile detachments Shaanxi Corps Shanxi Corps Shandong Corps Shanghai Corps Two mobile detachments
Sources: en.wikipedia.org
=== Optics === Cyclo Olefin Polymer (COP) is used for commercial optical applications because of its high insensitivity to moisture and thermal stability. COP has been used for polymer optical fibers because in addition to its optical qualities it maintains superior drawability over a wider temperature range than COC. Cyclo Olefin Polymer (COP) films are also used in applications that require low birefringence such as augmented reality and virtual reality, projector lenses and head-up displays. In augmented reality devices COP films are used as plastic optical waveguides resulting in near-glass like performance but with reduced mass. In addition, the improved flexibility allows for easier fabrication and more design freedom.
Using more reflux decreases the number of plates required and using less reflux increases the number of plates required. Hence, the calculation of Nt is usually repeated at various reflux rates. Nt is then divided by the tray efficiency, E, to determine the actual number of trays or physical plates, Na, needed in the separating column. The final design choice of the number of trays to be installed in an industrial distillation column is then selected based upon an economic balance between the cost of additional trays and the cost of using a higher reflux rate. There is a very important distinction between the theoretical plate terminology used in discussing conventional distillation trays and the theoretical plate terminology used in the discussions below of packed bed distillation or absorption or in chromatography or other applications. The theoretical plate in conventional distillation trays has no "height". It is simply a hypothetical equilibrium stage. However, the theoretical plate in packed beds, chromatography and other applications is defined as having a height. The empirical formula known as Van Winkle's Correlation can be used to predict the Murphree plate efficiency for distillation columns separating binary systems.
=== Adulteration and contamination === There are numerous cases of products falsely claiming to contain E. longifolia as an ingredient, as well as E. longifolia product contamination cases. In 2006, the U.S. Food and Drug Administration (FDA) banned seven dietary supplement products that claimed to include E. longifolia as a principal ingredient, but which additionally contained prescription drugs and even analogs of prescription drugs that have not yet been tested for safety in humans, such as acetildenafil. In 2017, the FDA announced that two different brands of E. longifolia-containing coffee were recalled after being found to be adulterated with active ingredients from erectile dysfunction drugs. In Malaysia, there are over 200 registered E. longifolia products. However, a 2004 study determined, following quality testing, that 36% of these were contaminated with mercury beyond legally permitted limits.
The colonies soon entered a relatively stable state based on cooperation, intermarriage, and official policies that provided social status, education, and professional training to children of mixed Aleut-Russian birth. Within a generation, the day-to-day administration of the Russian-American colonies was largely in the hands of native-born Alaskans. Reversing the usual trend in colonization where indigenous technologies are replaced, the Russians adopted the Aleut kayak, or baidarka, sea otter hunting techniques, and the working of native copper deposits. The Russians instituted public education, preservation of the Aleut language through transliteration of religious and other texts into Aleut via an adaptation of the Cyrillic alphabet, vaccination of the native population against smallpox, and science-based sea mammal conservation policies that were ahead of their time.
Sources: en.wikipedia.org
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.
Mass spectrometry gives the molecular mass, which is compared with the calculated value. Reversed-phase liquid chromatography shows purity and the presence of related impurities. Peptide mapping can verify the amino acid sequence when a higher level of detail is needed.
It reports the tests the supplier performed, which may vary between laboratories and lots. Methods and acceptance criteria are not standardised across suppliers. Buyers often request the actual chromatograms and spectra rather than a summary statement.
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.